Macrophage‐mediated cholesterol handling in atherosclerosis

  • Dimitry A. Chistiakov
    Division of Laboratory Medicine Department of Molecular Genetic Diagnostics and Cell Biology Institute of Pediatrics Research Center for Children's Health Moscow Russia
  • Yuri V. Bobryshev
    Faculty of Medicine and St Vincent's Centre for Applied Medical Research University of New South Wales Sydney NSW Australia
  • Alexander N. Orekhov
    Institute for Atherosclerosis Research Skolkovo Innovative Center Moscow Russia

書誌事項

公開日
2015-10-23
権利情報
  • http://creativecommons.org/licenses/by/4.0/
DOI
  • 10.1111/jcmm.12689
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>Formation of foam cells is a hallmark at the initial stages of atherosclerosis. Monocytes attracted by pro‐inflammatory stimuli attach to the inflamed vascular endothelium and penetrate to the arterial intima where they differentiate to macrophages. Intimal macrophages phagocytize oxidized low‐density lipoproteins (ox<jats:styled-content style="fixed-case">LDL</jats:styled-content>). Several scavenger receptors (<jats:styled-content style="fixed-case">SR</jats:styled-content>), including <jats:styled-content style="fixed-case">CD</jats:styled-content>36, <jats:styled-content style="fixed-case">SR</jats:styled-content>‐A1 and lectin‐like ox<jats:styled-content style="fixed-case">LDL</jats:styled-content> receptor‐1 (<jats:styled-content style="fixed-case">LOX</jats:styled-content>‐1), mediate ox<jats:styled-content style="fixed-case">LDL</jats:styled-content> uptake. In late endosomes/lysosomes of macrophages, ox<jats:styled-content style="fixed-case">LDL</jats:styled-content> are catabolysed. Lysosomal acid lipase (<jats:styled-content style="fixed-case">LAL</jats:styled-content>) hydrolyses cholesterol esters that are enriched in <jats:styled-content style="fixed-case">LDL</jats:styled-content> to free cholesterol and free fatty acids. In the endoplasmic reticulum (<jats:styled-content style="fixed-case">ER</jats:styled-content>), acyl coenzyme A: cholesterol acyltransferase‐1 (<jats:styled-content style="fixed-case">ACAT</jats:styled-content>1) in turn catalyses esterification of cholesterol to store cholesterol esters as lipid droplets in the <jats:styled-content style="fixed-case">ER</jats:styled-content> of macrophages. Neutral cholesteryl ester hydrolases <jats:styled-content style="fixed-case">nCEH</jats:styled-content> and <jats:styled-content style="fixed-case">NCEH</jats:styled-content>1 are involved in a secondary hydrolysis of cholesterol esters to liberate free cholesterol that could be then out‐flowed from macrophages by cholesterol <jats:styled-content style="fixed-case">ATP</jats:styled-content>‐binding cassette (<jats:styled-content style="fixed-case">ABC</jats:styled-content>) transporters <jats:styled-content style="fixed-case">ABCA</jats:styled-content>1 and <jats:styled-content style="fixed-case">ABCG</jats:styled-content>1 and <jats:styled-content style="fixed-case">SR</jats:styled-content>‐<jats:styled-content style="fixed-case">BI</jats:styled-content>. In atherosclerosis, disruption of lipid homoeostasis in macrophages leads to cholesterol accumulation and formation of foam cells.</jats:p>

収録刊行物

被引用文献 (11)*注記

もっと見る

問題の指摘

ページトップへ